Interferon Epsilon Loss Is Elusive 9p21 Link to Immune-Cold Tumors, Resistant to Immune Checkpoint Therapy, and Endogenous CXCL9/10 Induction

By afschroeder • September 7, 2025

Zhao X, Liu B, William WN, Tsanov KM, Ho YJ, Barriga FM, Lim RJ, Trifas M, Khandekar A, Du Y, Lowe SW, Dubinett SM, Davoli T, Lippman SM. Interferon Epsilon Loss Is Elusive 9p21 Link to Immune-Cold Tumors, Resistant to Immune Checkpoint Therapy, and Endogenous CXCL9/10 Induction. J Thorac Oncol. 2025 Sep;20(9):1177-1236. doi: 10.1016/j.jtho.2024.12.020. Epub 2024 Dec 24. PMID: 39725169.

Tags: chemokines, chromosome 9p, genomic copy number alterations, immunotherapy, interferons, Publications, Pulmonary, Critical Care & Sleep Medicine, TP53, vaccines

Evaluating selected gene therapies for cardiovascular diseases: an updated scoping review and evidence map of randomised controlled trials

Apaydin EA, Richard J, Miner SA, Waymouth M, Roberts D, Vockley J, Richardson AS. Evaluating selected gene therapies for cardiovascular diseases: an updated scoping review[...]

Interrelationships Between Kansas City Cardiomyopathy Questionnaire Domains, Age, and Sex for Patients With Heart Failure: Findings From the CHAMP-HF and CORC Registries

Girard AA, Jones PG, Fu Z, Sherrod CF 4th, Cantu Martinez O, Greene SJ, Bachmann JM, Fonarow GC, Butler J, Spertus JA, Arnold SV. Interrelationships[...]

Prevention Before Therapy in Pancreatic Ductal Adenocarcinoma: The Clinical, Economic, and Human Case for Weighting Resources Upstream

Eibl G, Hines OJ, Rozengurt E. Prevention Before Therapy in Pancreatic Ductal Adenocarcinoma: The Clinical, Economic, and Human Case for Weighting Resources Upstream. Cancer Prev[...]